Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $26.5400 (-6.88%) ($26.5400 - $26.5400) on Mon. May. 10, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.67% (three month average) | RSI | 36 | Latest Price | $26.5400(-6.88%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA declines -3.5% a day on average for past five trading days. | Weekly Trend | IOVA declines -4.7% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) IBB(45%) XBI(42%) ARKG(40%) IWO(39%) IWC(38%) | Factors Impacting IOVA price | IOVA will decline at least -1.835% in a week (0% probabilities). VIXM(-23%) UUP(-16%) VXX(-11%) TBT(-5%) UNG(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.835% (StdDev 3.67%) | Hourly BBV | -1.5 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $19.98(-24.72%) | Resistance Level | $30.5 | 5 Day Moving Average | $28.62(-7.27%) | 10 Day Moving Average | $30.13(-11.92%) | 20 Day Moving Average | $30.5(-12.98%) | To recent high | -45.4% | To recent low | 0% | Market Cap | $3.886b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |